• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Kirsty LEE

About Kirsty LEE

This author has not written his bio yet.
But we are proud to say that Kirsty LEE contributed 45 entries already.

Entries by Kirsty LEE

Baloxavir marboxil recommended as post-exposure prophylaxis to influenza by EMA

11 December 2020/0 Comments/in Gastrointestinal Cancer, Lung Cancer, Oncology, Targeted Therapies/by Kirsty LEE

Seasonal influenza is common between January to March, and July to August in Hong Kong. Baloxavir marboxil is the first influenza antiviral with a novel mechanism of action to be approved in almost two decades, and was registered for use in Hong Kong in February 2019.

Detecting metastases with PSMA-PET in prostate cancer

8 December 2020/1 Comment/in Genitourinary Cancer, Oncology, Surgery and Procedures, Targeted Therapies/by Kirsty LEE

Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.

ASCO Guidelines for the Use of Systemic Therapies in Advanced Hepatocellular Cancer

7 December 2020/0 Comments/in Gastrointestinal Cancer, Lung Cancer, Oncology, Immunotherapy, Guidelines, Targeted Therapies/by Kirsty LEE

Hepatocellular carcinoma (HCC) accounts for 80% of all liver cancers, and 55% of all HCC cases worldwide are reported from China. In Hong Kong, liver cancer is the fourth most common cancer and the third most common cause of cancer death.

Sotorasib for the treatment of KRASG12C mutated lung cancer

15 October 2020/0 Comments/in Gastrointestinal Cancer, Lung Cancer, Oncology, Targeted Therapies/by Kirsty LEE

RAS is the most frequently mutated gene family in cancers, with KRAS mutations being involved as a driver in three of the most lethal cancers – lung cancer, colorectal cancer, and pancreatic cancer. Incidence of KRAS mutations vary between ethnicity with Caucasians having a higher incidence than African-Americans or Asians. In non-small lung cancer (NSCLC), the most common KRAS mutation is G12C. In Asia, G12C mutations in particular account for 14.5% of KRAS mutations in the Chinese population. KRAS G12C was identified in 4.3% of lung cancer samples and 2.5% of colorectal cancer samples.

Capmatinib therapy for the treatment of MET-positive non-small cell lung cancer

15 October 2020/0 Comments/in Lung Cancer, Oncology, Targeted Therapies/by Kirsty LEE

A number of tyrosine kinase inhibitors (TKIs) are now available for the treatment of various types of non-small cell lung cancers (NSCLC), including epidermal growth factor receptor (EGFR)-mutated and anaplastic lymphoma kinase (ALK)-rearranged NSCLC. However, amplification of the MET gene, which codes for the hepatocyte growth factor receptor (HGFR), has been found to be one of the most prominent mechanisms of secondary resistance to EGFR TKIs. Similarly, the MET exon 14 (METex14) mutation has also emerged as a potential tumour driver due to its role in cancer proliferation, and thus also a promising target for NSCLC.

Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia

8 October 2020/0 Comments/in Cardiovascular/by Kirsty LEE

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.

Psoriasis biologics may help reduce coronary plaque

8 October 2020/0 Comments/in Cardiovascular, Rheumatology and AutoImmune Disorders/by Kirsty LEE

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.

Ticagrelor may not confer post-MI benefits to elderly patients

8 October 2020/0 Comments/in Cardiovascular/by Kirsty LEE

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.

Evidence of SARS-CoV2 in heart cells

22 September 2020/0 Comments/in COVID-19, SARS-CoV2, Cardiovascular, Pneumonia, Infectious Disease/by Kirsty LEE

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.

Triple combination effective for hospital- and ventilator-acquired pneumonia

10 September 2020/0 Comments/in Critical Care Medicine, Pneumonia, Infectious Disease/by Kirsty LEE

Pneumonia is the second leading cause of death in Hong Kong as of 2019, with annually increasing death rates.

Page 3 of 512345

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only